A Multinational, Single Arm, Observational Study to Evaluate the Real-
Research payments
$378,990
Through program year 2022, $378,990 in research payments was reported against A Multinational, Single Arm, Observational Study to Evaluate the Real-, across 327 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $115,845 | 112 |
| 2021 | Research | $28,540 | 43 |
| 2020 | Research | $82,429 | 89 |
| 2019 | Research | $152,175 | 83 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Tariq Cheema Pittsburgh, PA Named on 22 payments
- Frances Lee Atlanta, GA Named on 17 payments
- Vijay Subramaniam Williamsburg, VA Named on 15 payments
- David Hill Waterbury, CT Named on 12 payments
- Muhammad Rais Colonial Heights, VA Named on 10 payments
- Jacob Offenberger Granada Hills, CA Named on 9 payments
- Stephen Gorman South Portland, ME Named on 8 payments
- Brian Lipson Hayward, CA Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.